Semaglutide
Recorded for Human+ · Oral · dosage form not recorded · every semaglutide record
The program identifies an oral medicine, but the precise dosage form and administration instructions have not been established.
Price
No comparable monthly price verified at this reading. See dated notes for any advertised starting figures.
Current availability of this program is not verified.
We earn nothing from this link. It opens Human+'s website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- November 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Assigned dispensing pharmacy not disclosed. DrTelx is named as an independent medical group; EPIQ Scripts, Foothills Pharmacy and Emerald Compounding Pharmacy are network partners, not an assigned dispenser for this prescription. |
|---|---|
| States | Oral-semaglutide eligible-state roster not disclosed. General 50-state/DC service advertising does not establish availability or eligibility for the footer-only oral-semaglutide listing. |
| Prescriber | Oral-semaglutide consultation format not disclosed. General services describe questionnaire-based and live care, but the footer-only listing does not establish this offering’s consultation pathway. |
| Cancellation | Cancellation and refund conditions not disclosed. Public legal/refund links point to same-page placeholders; no medication-specific cancellation deadline, renewal payment or refund conditions are established. |
| Membership | Oral-semaglutide membership charge not disclosed. The body advertises no membership fees for its three named programs. The footer-only oral-semaglutide listing does not establish whether that statement applies to this additional offering. |
| Consult fee | Itemized consultation charge not disclosed. The general safety disclosure places clinician prescription assessment after checkout. The footer-only oral-semaglutide listing does not establish its own consultation pathway or itemized consultation charge. |
Recorded from turnhumanplus.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. November 2026 — The public footer explicitly labels “Oral semaglutide” but points to a same-page placeholder; the body instead lists semaglutide injection and tirzepatide injection/oral. This is an unresolved catalog indication, not confirmed current fulfillment. The ingredient/route label is preserved without assigning compounded or branded formulation, dosage form, payment or supply. https://turnhumanplus.com/
- 2. November 2026 — The page advertises one flat price, shipping included, no membership fees and no dose upcharges. No numeric treatment amount, payment interval, selected supply or initial/renewal invoice is published in the captured page. These are general service descriptions; their applicability to the footer-only oral-semaglutide offering is not established. https://turnhumanplus.com/
- 3. November 2026 — The safety disclosure names DrTelx as an independent medical group and EPIQ Scripts, Foothills Pharmacy and Emerald Compounding Pharmacy as network partners. Another footer passage references CareGLP affiliated professional entities. These statements do not identify the individual treating clinician or assigned dispensing pharmacy. These are general service descriptions; their applicability to the footer-only oral-semaglutide offering is not established. https://turnhumanplus.com/
- 4. November 2026 — The disclosure describes questionnaire-based care in 44 states and requires live consultation in DC, KS, LA, MS, NM, RI and WV. General 50-state/DC service advertising does not establish availability of each medication. The safety disclosure says a clinician meets with an individual after checkout to determine prescription eligibility. Provider review of intake and labs is described, without establishing required laboratory tests, included testing or laboratory charges. These are general service descriptions; their applicability to the footer-only oral-semaglutide offering is not established. https://turnhumanplus.com/
- 5. November 2026 — Medication is described as included in the program. Separate consultation charges, laboratory fees and minimum enrollment or supply terms are not established. The site says no insurance is needed; that statement alone does not prove insurance acceptance or reimbursement. These are general service descriptions; their applicability to the footer-only oral-semaglutide offering is not established. https://turnhumanplus.com/
- 6. November 2026 — Terms, privacy, refund and medical-consent links are same-page placeholders in the captured homepage. No cancellation cutoff, automatic renewal schedule or refund entitlement is established. https://turnhumanplus.com/
11 further notes concern other Human+ programs and sit on the provider record.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.